Patterns of gastritis in patients with gastro-oesophageal reflux disease

Gut

Volumn 45, Issue 6, 1999, Pages 798-803

  Bowrey, D J ^a,b   Clark, G W B ^a   Williams, G T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NEVILL HALL HOSPITAL   (United Kingdom)

Author keywords

Cardiac mucosa; Carditis; Gastro oesophageal junction; Gastro oesophageal reflux; Helicobacter pylori; Inflammation

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BARRETT ESOPHAGUS; CARDIA; CELL INFILTRATION; DISEASE ASSOCIATION; ESOPHAGOSCOPY; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; GIEMSA STAIN; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH FUNDUS; STOMACH GLAND; STOMACH MUCOSA;

EID: 0032759696     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.6.798     Document Type: Article

References (62)

1. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-3.
2. Bloi WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
3. Cameron AJ, Ou BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
4. Hameeteman W, Tytgat GN, Houthoff HJ, et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249-56.
5. Van der Veen AH, Dees J, Blankensteijn JD, et al. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989;30:14-18.
6. Williamson WA, Ellis FH Jr, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-16.
7. Iftikhar SY, James PD, Steele RJ, et al. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
8. Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-8.
9. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-15.
10. Katz D, Rothstein R, Schned A, et al. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-41.
11. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-6.
12. Johnston MH, Hammond AS, Laskin W, et al. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;591:1507-11.
13. Chalasani N, Wo JM, Hunter JG, et al. Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sci 1997;42:603-7.
14. Morales TG, Sampliner RE, Bhattacharyya A. Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997;92:414-18.
15. Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-15.
16. Oberg S, Peters JH, DeMeester TR, et al. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997;226:522-32.
17. Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-9.
18. Dias Pereira A, Suspiro A, Chaves P, et al. Short segments of Barett's epithelium and intestinal metaplasia in normal appearing oesophagogastric junctions: the same or two different entities? Gut 1998;42:659-62.
19. Goldblum JR, Vicari JJ, Falk GW, et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux disease and H pylori infection. Gastroenterology 1998;114:633-9.
20. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998;43:17-21.
21. Clark GW, Ireland AP, Chandrasoma P, et al. Inflammation and metaplasia in the transitional epithelium of the gastroesophageal junction: a new marker for gastroesophageal reflux disease [abstract]. Gastroenterology 1994;106:A63.
22. Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "carditis", and Barrett's esophagus, and sequelae of therapy [review]. Am J Surg Pathol 1996;20(suppl 1):S31-50.
23. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
24. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25:317-22.
25. Bowrey DJ, Williams GT, Clark GWB. Interactions between Helicobacter pylori and gastroesophageal reflux disease [review]. Dis Esophagus 1998;11;203-9.
26. Hawthorne AB, Morgan S, Stenson R, et al. Validation of two near-patient whole blood tests for Helicobacter pylori. How near are they to a gold standard? [abstract]. Gut 1997;41(suppl 4):A159.
27. Sampliner RE and the Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998;93:1028-32.
28. Owen DA. Normal histology of the stomach [review]. Am J Surg Pathol 1986;10:48-61.
29. Spicer SS. Diamine methods for differentiating mucosubstances histochemically. J Histochem Cytochem 1965;13:211-34.
30. Filipe MI, Lake BD, eds. Histochemistry in pathology. Edinburgh: Churchill Livingstone, 1983:310-13.
31. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-19.
32. Hackelsberger A, Gunther T, Schultze V, et al. Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol 1997;12:2220-4.
33. Thijs JC, van Zwei AA, Thijs WJ, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol 1996;91:2125-9.
34. Lerang F, Mourn B, Mowinckel P, et al. Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results. Scand J Gastroenterol 1998;33:364-9.
35. Luthra GK, DiNuzzo AR, Gourley WK, et al. Comparison of biopsy and serological methods of diagnosis of Helicobacter pylori infection and the potential role of antibiotics. Am J Gastroenterol 1998;93:1291-6.
36. Dooley CP, Cohen H, Fitzgibbons PL, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989;321:1562-6.
37. Megraud F. Epidemiology of Helicobacter pylori infection [review]. Gastroenterol Clin N Am 1993;22:73-88.
38. Buckley MJM, O'Shea J, Grace A, et al. A community-based study of the epidemiology of Helicobacter pylori infection and associated asymptomatic gastroduodenal pathology. Eur J Gastroenterol Hepatol 1998;10:375-9.
39. Vicari JJ, Peck RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998;115;50-7.
40. Dixon MF, O'Connor HJ, Axon AT, et al. Reflux gastritis: distinct histopathological entity? J Clin Pathol 1986;39:524-30.
41. Sobala GM, King RF, Axon AT, et al. Reflux gastritis in the intact stomach. J Clin Pathol 1990;43:303-6.
42. Sobala GM, O'Connor HJ, Dewar EP, et al. Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol 1993;46:235-40.
43. Houghton PW, Mortensen NJ, Thomas WE, et al. Intragastric bile acids and histological changes in gastric mucosa. Br J Surg 1986;73:354-6.
44. Byrne JP, Bhatnagar S, Hamid B, et al. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy. Am J Gastroenterol
45. Voutilainen M, Farkkila M, Juhola M, et al. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. Am J Gastroenterol 1999;94:913-18.
46. Hirota WK, Loughney TM, Loans DJ, et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-85.
47. Krause WJ, Ivey KJ, Baskin WN, et al. Morphological observations on the normal human cardiac glands. Anat Rec 1978;192:59-72.
48. Stachura J, Krause WJ, Ivey KJ. Endocrine cells in human cardiac glands. Folia Histochem Cytochem 1981;19:71-6.
49. Bensley RR. The cardiac glands of mammals. Am J Anat 1902;2:105-56.
50. Muller Botha GS. The gastro-oesophageal junction. Clinical applications to oesophageal and gastric surgery. London: J & A Churchill Ltd, 1962.
51. Miyagawa Y. The exact distribution of the gastric glands in man and in certain animals. J Anat 1972;55:56-67.
52. Ellison E, Hassall E, Dimmick JE. Mucin histochemistry of the developing gastroesophageal junction. Pediatr Pathol Lab Med 1996;16:195-206.
53. Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia is not a metaplastic mucosa secondary to gastroesophageal reflux disease (GERD) [abstract]. Gastroenterology 1999;116:A213.
54. Ormsby AH, Goldblum JR, Kilgore SP, et al. The frequency and nature of cardiac mucosa and intestinal metaplasia (IM) of the esophagogastric junction (EGJ): a population based study of 223 consecutive autopsies [abstract]. Gastroenterology 1999;116:A273.
55. Domeneghini C, Castaldo L. The endocrine cells of the bovine cardiac glands. Bas Appl Histochem 1981;25:51-66.
56. Filipe MI, Potet F, Bogomoletz WV, et al. Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut 1985;26:1319-26.
57. Matsukura N, Suzuki K, Kawachi T, et al. Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation of complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst 1980;65:231-40.
58. Jass JR. Mucin histochemistry of the columnar epithelium of the oesophagus: a retrospective study. J Clin Pathol 1981;34:866-70.
59. Peuchmaur M, Potet F, Goldfain D. Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's oesophagus): a prospective biopsy study. J Clin Pathol 1984;37:607-10.
60. Haggitt RC, Reid BJ, Rabinovitch PS, et al. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk. Am J Pathol 1988;131:53-61.
61. Lapertosa G, Baracchini P, Fulcheri E, et al. Mucin histochemical analysis in the interpretation of Barrett's esophagus. Am J Clin Pathol 1992;98:61-6.
62. Torrado J, Ruiz B, Garay J, et al. Blood-group phenotypes, sulfomucins, and Helicobacter pylori in Barrett's esophagus. Am J Surg Pathol 1997;21:1023-9.